Numinus Wellness, Inc engages in the development of psychedelic-centered therapeutic products and services. It operates through the following segments: Numinus Bioscience, Numinus Health, Mindspace, and Corporate. The Numinus Bioscience segment extracts natural Psilocybe and other psychoactive fungi species, and develops proprietary processes and products. The Numinus Health segment offers the therapeutic use of psychedelics in accordance with regulatory approvals to deliver additional health and wellness solutions to the market. The Mindspace segment provides clinic services with a focus evidence-based approaches to mental health, which delivers health and wellness solutions to the Quebec market. The company was founded on June 26, 1962 and is headquartered in Vancouver, Canada.